gimli
IPCALAB stock analysis context
IPCA LABORATORIES Stock Context for AI Screening
IPCA LABORATORIES LTD is a mid-cap stock in Healthcare. This page summarizes key screening signals for IPCA LABORATORIES, including recent returns, momentum indicators, valuation ratios, liquidity, and growth metrics. Gimli uses this context to help users ask natural-language stock screening questions across Indian equities.
Ask Gimli about IPCALABPrice
₹1,602.10
1M return
+7.18%
3M return
+10.50%
Market cap
₹40,645.95 cr
PE
44.67
ROE
+11.29%
RSI
57.87
Turnover
₹16.06 cr
Why it can matter in screens
- Momentum: IPCALAB is above 50DMA, above 200DMA; RSI is 57.87.
- Returns: 1M +7.18%, 3M +10.50%, 6M +10.95%.
- Liquidity: latest turnover is ₹16.06 cr.
- Valuation: PE 44.67, PB n/a, ROE +11.29%, ROCE +14.51%.
- Growth: 3Y sales CAGR +15.36%, 3Y profit CAGR -5.85%.
Try these prompts
- Analyze IPCA LABORATORIES with valuation, momentum and industry peers
- Compare IPCALAB with other Healthcare stocks
- Show mid-cap stocks in Healthcare above 50DMA with positive 1M return
- Find Healthcare stocks with improving momentum and reasonable valuation
Related screen ideas
- View Healthcare stocks
- View mid-cap stocks
- Find stocks above 50DMA
- Compare IPCALAB with other Healthcare stocks
Data snapshot: 2026-05-22. Not investment advice.